「Yes-associated protein 1 mediates initial cell survival during lorlatinib treatment through AKT signaling in ROS1-rearranged lung cancer」の関連論文
-
Cryptotanshinone, a novel PDK 4 inhibitor, suppresses bladder cancer cell invasiveness via the mTOR/β‑catenin/N‑cadherin axis.
-
Mac-2-binding protein glycan isomer enhances the aggressiveness of hepatocellular carcinoma by activating mTOR signaling.
-
Comprehensive genomics in androgen receptor-dependent castration-resistant prostate cancer identifies an adaptation pathway mediated by opioid receptor kappa 1
-
Design of Novel Targeted Co-delivery System for Combined Chemotherapy and Gene Therapy of Hepatocellular Carcinoma [an abstract of entire text]
-
Clinical and Basic Research for Ovarian Cancer
-
Suppression of malignant rhabdoid tumors through Chb-M′-mediated RUNX1 inhibition
-
Inhibition of Dopamine Receptor D1 Signaling Promotes Human Bile Duct Cancer Progression via WNT signaling
-
An HSP90 inhibitor overcomes EGFR amplification-induced resistance to third-generation EGFR-TKIs
-
Expression of Ferredoxin1 in cisplatin‑resistant ovarian cancer cells confers their resistance against ferroptosis induced by cisplatin
-
Studies on Cytotoxic Effects of Tumor Necrosis Factor-Related Apoptosis Inducing Ligand (TRAIL) to Canine Cell Lines Derived from Hemangiosarcoma and Mammary Epithelial Tumor
-
Clinical significance of BIM deletion polymorphism on chemoradiotherapy in patients with non-small cell lung cancer.
-
Clinical significance of BIM deletion polymorphism on chemoradiotherapy in patients with non-small cell lung cancer.
-
JNK pathway plays a critical role for expansion of human colorectal cancer in the context of BRG1 suppression
-
T-cell response to phytohemagglutinin in the interferon-γ release assay as a potential biomarker for the response to immune checkpoint inhibitors in patients with non-small cell lung cancer
-
Effects of Senkyunolide I on ischemic cell injury and neurogenesis
-
タクロリムスによる神経毒性の発現メカニズムの解明と予防薬の探索
-
JNK and Yorkie drive tumor malignancy by inducing L-amino acid transporter 1 in Drosophila
-
Inhibition of cell-surface molecular GPR87 with GPR87-suppressing adenoviral vector disturb tumor proliferation in lung cancer cells
-
Blockade of EGFR improves responsiveness to PD-1 blockade in EGFR-mutated non–small cell lung cancer
-
The effect of gemcitabine on cell cycle arrest and microRNA signatures in pancreatic cancer cells
-
Antiapoptotic Effect by PAR-1 Antagonist Protects Mouse Liver Against Ischemia-Reperfusion Injury
-
Efficacy of the Novel Tubulin Polymerization Inhibitor PTC-028 for Myelodysplastic Syndrome
-
Luteolin suppress bladder cancer growth via regulation of mechanistic target of rapamycin (mTOR) pathway
-
TSC22D4/THG-1 suppresses cellular senescence in esophageal squamous cell carcinoma
-
The role of vagus nerve stimulation through acetylcholine receptor during atherosclerosis progression
-
FXYD3 functionally demarcates an ancestral breast cancer stem cell subpopulation with features of drug-tolerant persisters
-
Regulation of Cell Motility by La-Related Protein 4 in Ovarian Cancer Cell
-
The Interaction between Cancer-associated Fibroblasts and Cancer Cells Enhances Bcl-xL and Mcl-1 in Colorectal Cancer
-
Cryptotanshinone suppresses tumorigenesis by inhibiting lipogenesis and promoting reactive oxygen species production in KRAS‑activated pancreatic cancer cells
-
SPC18 expression is an independent prognostic indicator of patients with esophageal squamous cell carcinoma
-
SPC18 expression is an independent prognostic indicator of patients with esophageal squamous cell carcinoma
-
Placental growth factor is a predictive biomarker for ramucirumab treatment in advanced gastric cancer
-
Tumor elimination by clustered microRNAs miR-306 and miR-79 via noncanonical activation of JNK signaling
-
Significance of Wnt/β-Catenin Signal Activation for Resistance to Neoadjuvant Chemoradiotherapy in Rectal Cancer
-
Activation of BAX and BAK is an attractive combination therapy in melanoma
-
A RUNX-targeted gene switch-off approach modulates the BIRC5/PIF1-p21 pathway and reduces glioblastoma growth in mice
-
Hippo-TAZ signaling is the master regulator of the onset of triple-negative basal-like breast cancers
-
PTEN is a predictive biomarker of trastuzumab resistance and prognostic factor in HER2-overexpressing gastroesophageal adenocarcinoma
-
AITC inhibits fibroblast-myofibroblast transition via TRPA1-independent MAPK and NRF2/HO-1 pathways and reverses corticosteroids insensitivity in human lung fibroblasts
-
Doublecortin-like kinase 1 expression is induced by alternative NF-κB signaling in human lung cancer cells
-
Transcutaneous carbon dioxide application suppresses the expression of cancer-associated fibroblasts markers in oral squamous cell carcinoma xenograft mouse model
-
An oral cancer vaccine using Bifidobacterium vector augments combination of anti-PD-1 and anti-CTLA-4 antibodies in mouse renal cell carcinoma model
-
Antioxidants and Therapeutic Targets in Ovarian Clear Cell Carcinoma.
-
Study on the biological significance of YAP gene alternative splicing
-
Polarity switching of ovarian cancer cell clusters via SRC family kinase is involved in the peritoneal dissemination
-
Combination of tumor necrosis factor-α and epidermal growth factor induces the adrenergic-to-mesenchymal transdifferentiation in SH-SY5Y neuroblastoma cells
-
Cancer-specific targeting of taurine upregulated gene 1 enhances the effects of chemotherapy in pancreatic cancer
-
Enhanced anti-tumor effects of the PD-1 blockade combined with a highly absorptive form of curcumin targeting STAT3 (本文)
-
Sasa veitchii extract induces anticancer effects via inhibition of cyclin D1 expression in MCF-7 cells
-
Functional visualization of NK Cell-mediated killing of metastatic single tumor cells